Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
HotSpot Therapeutics Presents Additional Phase 1 Biomarker Data on Novel CBL-B Inhibitor HST-1011 at 2024 Society for Immunotherapy of Cancer Annual Meeting
-
Jarrod Yahes Will Join Unity as Chief Financial Officer
-
Sapience Therapeutics Announces Participation at the Jefferies London Healthcare Conference
-
Smith Micro Schedules Teleconference to Announce Third Quarter 2024 Financial Results
-
Identiv Announces $10 Million Stock Repurchase Program and Proposes Corporate Governance Enhancements
-
Fathom Holdings Reports Third Quarter 2024 Results
-
QuidelOrtho Reports Third Quarter 2024 Financial Results
-
System1 Announces Strong Third Quarter 2024 Financial Results
-
SkyWater Technology Reports Third Quarter 2024 Results
-
Lam Research Corporation Declares Quarterly Dividend
-
RingCentral Announces Third Quarter 2024 Results
-
Natural Grocers by Vitamin Cottage, Inc. Announces Fourth Quarter and Fiscal Year 2024 Earnings Conference Call and Webcast
-
Adaptive Biotechnologies Reports Third Quarter 2024 Financial Results
-
nLIGHT, Inc. Announces Third Quarter 2024 Results
-
a.k.a. Brands Holding Corp. Reports Third Quarter 2024 Financial Results
-
Spyre Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update
-
Mobile Infrastructure to Present at Sidoti Micro Cap Virtual Conference on November 14
-
AvePoint Announces Third Quarter 2024 Financial Results
-
Alaska Communications Secures Long-Term Funding for Expanding Broadband
-
Aptiv Announces Leadership Appointments
-
Airbnb Announces Third Quarter 2024 Results
-
Avidity Biosciences Reports Third Quarter 2024 Financial Results and Recent Highlights
-
MasterBrand to Present at Baird’s Global Industrial Conference
-
Block Announces Third Quarter 2024 Results
-
GitLab Chief Product Officer David DeSanto to Present at the RBC Capital Markets Global Technology, Internet, Media and Telecommunications Conference
-
TaskUs Announces Fiscal Third Quarter 2024 Results
-
Nu Skin Enterprises Announces Quarterly Dividend
-
Lantern Pharma Reports Third Quarter 2024 Financial Results and Business Updates
-
LightPath Technologies Reports First Quarter Fiscal 2025 Financial Results
-
Puma Biotechnology Reports Third Quarter 2024 Financial Results
-
Jamieson Wellness Inc. Reports Third Quarter 2024 Results
-
Lyell Immunopharma Reports Business Highlights and Financial Results for the Third Quarter 2024
-
Inogen Announces Third Quarter 2024 Financial Results
-
Golden Entertainment Reports 2024 Third Quarter Results
-
Affirm Reports First Fiscal Quarter 2025 Results
-
Kura Oncology Reports Third Quarter 2024 Financial Results
-
Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
-
Amprius Technologies Reports Third Quarter 2024 Business and Financial Results
-
CytoSorbents Reports Third Quarter 2024 Financial and Operational Results
-
Jeff’s’ Brands Initiates Strategic Plan by Entering into a Non-Binding Letter of Intent to Sell Subsidiary to a U.S. Public Company at a valuation of approximately $13.125 million
-
Lifetime Brands, Inc. Reports Third Quarter 2024 Financial Results
-
Definitive Healthcare Reports Financial Results for Third Quarter Fiscal Year 2024
-
Ecolab Schedules Webcast of Industry Conference for November 13, 2024
-
ADMA Biologics Announces Third Quarter 2024 Financial Results and Provides Business Update
-
RxSight, Inc. Reports Third Quarter 2024 Financial Results
-
CarGurus Announces Third Quarter 2024 Results
-
Santander Bank Lowers Its Prime Rate to 7.75%
-
Robinhood Markets, Inc. to Present at the Wolfe Research Wealth Symposium on November 13, 2024
-
Pulmonx to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
-

